• By Dana Sparks

More Reaction to Alzheimer’s Drug Trial Results

August 24, 2012

For news outlets covering the solanezumab Alzheimer’s drug trial results, neurologist Richard Caselli, M.D., commented from Mayo Clinic in Arizona.

Sound bites with Dr. Caselli are available in the downloads above.

Expert title for broadcast cg : Dr. Richard Caselli, Mayo Clinic Neurologist

To interview Dr. Caselli, please contact Public Affairs:
480-301-4222 (days)
480-301-8000 (evenings)